Related Experiment Video
Updated: Aug 6, 2026
09:01
Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
Sphingolipid players in the leukemia arena
Clara Ricci1, Francesco Onida, Riccardo Ghidoni
1Laboratory of Biochemistry and Molecular Biology, San Paolo University Hospital, Medical School, University of Milan, 20142 via A. di Rudinì, 8-Milan, Italy.
Biochimica Et Biophysica Acta
|August 15, 2006
Summary
Sphingolipids are key in cell processes and leukemia. Modulating sphingolipid metabolism offers new strategies for leukemia treatment and overcoming drug resistance.
Area of Science:
- Biochemistry
- Cell Biology
- Oncology
Background:
- Sphingolipids are vital for cellular functions including proliferation, survival, differentiation, and apoptosis.
- Dysregulation of sphingolipid metabolism is implicated in various cancers, including hematological malignancies.
Purpose of the Study:
- To review the biological and clinical aspects of leukemias.
- To summarize the role of sphingolipids in apoptosis induction by anti-leukemic agents.
- To explore therapeutic strategies involving sphingolipid metabolism modulation for leukemia treatment.
Main Methods:
- Literature review of sphingolipid metabolism in cancer.
- Analysis of sphingolipids as mediators of apoptosis in leukemia.
- Evaluation of therapeutic potential and resistance mechanisms.
Main Results:
- Sphingolipids mediate apoptosis induced by anti-leukemic agents and analogs.
- Molecules modulating sphingolipid metabolism show promise for leukemia therapy.
- Deregulation of sphingolipid metabolism is linked to therapy resistance in vitro and in vivo.
Conclusions:
- Sphingolipids are crucial mediators in leukemia cell death pathways.
- Targeting sphingolipid metabolism presents a promising avenue for novel leukemia treatments.
- Sphingolipids can be targeted to overcome drug resistance in leukemia therapy.
Related Concept Videos
01:15Differentiation of Common Myeloid Progenitor Cells
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
01:01Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...